Compile Data Set for Download or QSAR
Report error Found 119 Enz. Inhib. hit(s) with all data for entry = 6036
TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 41571BDBM41571(US8569281, 52)
Affinity DataKi:  0.300nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105075BDBM105075(CHEMBL2152708 | US8569281, 59)
Affinity DataKi:  2.40nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105125BDBM105125(US8569281, 147)
Affinity DataKi:  3nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105080BDBM105080(US8569281, 70)
Affinity DataKi:  3nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105100BDBM105100(US8569281, 110)
Affinity DataKi:  3nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105093BDBM105093(US8569281, 100)
Affinity DataKi:  5nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105092BDBM105092(US8569281, 98)
Affinity DataKi:  5nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105124BDBM105124(US8569281, 146)
Affinity DataKi:  5nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105115BDBM105115(US8569281, 132)
Affinity DataKi:  5nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105176BDBM105176(US8569281, 216)
Affinity DataKi:  6nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105071BDBM105071(US8569281, 39)
Affinity DataKi:  6nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105091BDBM105091(US8569281, 96)
Affinity DataKi:  6nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105101BDBM105101(US8569281, 111)
Affinity DataKi:  6nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105065BDBM105065(US8569281, 14)
Affinity DataKi:  6nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105180BDBM105180(US8569281, 224)
Affinity DataKi:  7nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105143BDBM105143(US8569281, 168)
Affinity DataKi:  7nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105148BDBM105148(US8569281, 175)
Affinity DataKi:  7nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105177BDBM105177(US8569281, 218)
Affinity DataKi:  8nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105103BDBM105103(US8569281, 114)
Affinity DataKi:  9nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105174BDBM105174(US8569281, 212)
Affinity DataKi:  9nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105163BDBM105163(US8569281, 201)
Affinity DataKi:  9nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105104BDBM105104(US8569281, 116)
Affinity DataKi:  10nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105171BDBM105171(US8569281, 209)
Affinity DataKi:  10nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105114BDBM105114(US8569281, 129)
Affinity DataKi:  10nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105090BDBM105090(US8569281, 93)
Affinity DataKi:  11nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105172BDBM105172(US8569281, 210)
Affinity DataKi:  11nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105175BDBM105175(US8569281, 213)
Affinity DataKi:  12nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105166BDBM105166(US8569281, 204)
Affinity DataKi:  12nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105128BDBM105128(US8569281, 150)
Affinity DataKi:  12nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105158BDBM105158(US8569281, 190)
Affinity DataKi:  13nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105120BDBM105120(US8569281, 140)
Affinity DataKi:  13nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105156BDBM105156(US8569281, 186)
Affinity DataKi:  13nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105118BDBM105118(US8569281, 138)
Affinity DataKi:  13nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105084BDBM105084(US8569281, 78)
Affinity DataKi:  13nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105119BDBM105119(US8569281, 139)
Affinity DataKi:  14nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105062BDBM105062(US8569281, 6)
Affinity DataKi:  14nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105077BDBM105077(US8569281, 64)
Affinity DataKi:  14nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105173BDBM105173(US8569281, 211)
Affinity DataKi:  15nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105150BDBM105150(US8569281, 177)
Affinity DataKi:  16nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105063BDBM105063(US8569281, 8)
Affinity DataKi:  17nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105129BDBM105129(US8569281, 151)
Affinity DataKi:  17nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105073BDBM105073(US8569281, 54)
Affinity DataKi:  18nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105165BDBM105165(US8569281, 203)
Affinity DataKi:  18nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 41572BDBM41572(US8569281, 57)
Affinity DataKi:  19nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105074BDBM105074(US8569281, 56)
Affinity DataKi:  19nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105110BDBM105110(US8569281, 124)
Affinity DataKi:  19nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105109BDBM105109(US8569281, 123)
Affinity DataKi:  20nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105160BDBM105160(US8569281, 197)
Affinity DataKi:  21nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105169BDBM105169(US8569281, 207)
Affinity DataKi:  21nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

TargetLeucine-rich repeat serine/threonine-protein kinase 2(Human)
Medical Research Council Technology

US Patent
LigandChemical structure of BindingDB Monomer ID 105094BDBM105094(US8569281, 101)
Affinity DataKi:  22nMAssay Description:This assay was used to determine a compound's potency in inhibiting activity of LRRK2 by determining Kiapp, IC50 or percent inhibition values.More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/24/2014
Entry Details
US Patent

Displayed 1 to 50 (of 119 total ) | Next | Last >>
Jump to: